Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-12-30: Form 6-K; Period of report 2025-12-30; Description 6-K; Document d214993d6k.htm.
- 2025-12-10: Form 6-K; Period of report 2025-12-10; Description 6-K; Document d65335d6k.htm.
- 2025-11-26: Form 6-K; Period of report 2025-11-25; Description 6-K; Document d24094d6k.htm.
- 2025-11-12: Form 6-K; Period of report 2025-11-12; Description 6-K; Document d23481d6k.htm.